KRS Capital Management’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,150	Closed	-$125K	–	202
2021 Q4	$125K	Buy	+2,150	New	+$125K	0.11%	155